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BRIEF REPORTS
Drug Utilization and Inappropriate Prescribing in Centenarians
Nisha C. Hazra, MSc,* Alex Dregan, PhD,*† Stephen Jackson, MD,‡ and Martin C. Gulliford,
FPPH*†
OBJECTIVES: To use primary care electronic health
records (EHRs) to evaluate prescriptions and inappropriate
prescribing in men and women at age 100.
DESIGN: Population-based cohort study.
SETTING: Primary care database in the United Kingdom,
1990 to 2013.
PARTICIPANTS: Individuals reaching the age of 100
between 1990 and 2013 (N = 11,084; n = 8,982 women,
n = 2,102 men).
MEASUREMENTS: Main drug classes prescribed and
potentially inappropriate prescribing according to the
2012 American Geriatrics Society Beers Criteria.
RESULTS: At the age of 100, 73% of individuals (79%
of women, 54% of men) had received one or more pre-
scription drugs, with a median of 7 (interquartile range 0–
12) prescription items. The most frequently prescribed
drug classes were cardiovascular (53%), central nervous
system (CNS) (53%), and gastrointestinal (47%). Overall,
32% of participants (28% of men, 32% of women) who
received drug prescriptions may have received one or more
potentially inappropriate prescriptions, with temazepam
and amitriptyline being the most frequent. CNS prescrip-
tions were potentially inappropriate in 23% of individuals,
and anticholinergic prescriptions were potentially inappro-
priate in 18% of individuals.
CONCLUSION: The majority of centenarians are pre-
scribed one or more drug therapies, and the prescription
may be inappropriate for up to one-third of these indivi-
duals. Research using EHRs offers opportunities to under-
stand prescribing trends and improve pharmacological care
of the oldest adults. J Am Geriatr Soc 2016.
Key words: centenarians; epidemiology; inappropriate
prescribing; aging; primary care
Remarkable reductions in mortality are associated withrapid increases in life expectancy in many developed
countries. Recent estimates in the United Kingdom (UK)
indicate a quintupling of the number of centenarians over
the past 3 decades, to 13,780 in 2013.1 This trend is
expected to continue, with approximately 68,000 centenar-
ians in the United Kingdom2 and 1 million centenarians
worldwide by 2030.3,4 Greater longevity is likely to be
associated with higher rates of drug prescribing and
greater expenditures on health services.5 Elderly people
consume 45% to 55% of all drugs in the United King-
dom,6,7 and 38% of all drugs in the United States,8 but
few studies in the United Kingdom have described drug
utilization and none have described potentially inappropri-
ate prescribing (PIP) in the oldest adults.
Drug prescribing and managing medication use in
older adults is complex and challenging because multiple
morbidity, frailty, and cognitive impairment often accom-
pany old age. Drug prescribing in very old adults is chal-
lenging to clinicians because very old adults often require
multiple drug therapy but are also at great risk of drug-
related adverse effects. Evidence regarding drug prescribing
in centenarians is rare and, when available, rather incon-
sistent.9–12 Existing studies include self-reported data and
tend to focus on younger old people,7,9,10,12 often exclud-
ing centenarians.9,13,14
Electronic health records (EHRs) are a valuable
resource to explore the epidemiology of drug prescribing in
population-based samples.12 Electronic data can help over-
come biases in self-reported prescribing patterns and medi-
cal histories, a common limitation of previous studies.7,15–
17 The central role of general practice within the U.K.
National Health Service allows for long-term prescribing to
be managed in primary care. This study aimed to use pri-
mary care EHR data from the U.K. Clinical Practice
Research Datalink (CPRD), one of the world’s largest pri-
mary care databases, to describe drug use and to estimate
the frequency of PIP in a large cohort of centenarians.
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METHODS
Setting and Study Design
The study included a nationally representative sample of
individuals in primary care from the CPRD who reached the
age of 100 between 1990 and 2013, as described previ-
ously.18 Practices can contribute data only when it is
deemed of sufficient quality for research, according to a set
of criteria that the CPRD group has developed.19 This study,
which received scientific and ethical approval from the Inde-
pendent Scientific Advisory Committee for CPRD studies
(ISAC Protocol 13_151), is based on fully anonymized data,
and research ethics committee approval was not required.
Participants
A population-based cohort of centenarians was drawn
from the CPRD between January 1, 1990, and September
30, 2013, as previously described.18 Eligible participants
were registered at CPRD general practices during the year
in which they turned 100.
Measures
Drug utilization was first evaluated using the main chap-
ters from the British National Formulary (BNF) as cate-
gories. The BNF is published every 6 months and provides
healthcare professionals with up-to-date information about
medicines.20 Each participant’s record was evaluated for
drug prescriptions in the following drug categories: gas-
trointestinal; cardiovascular; respiratory; central nervous
system (CNS); antimicrobial; endocrine; gynecological and
urinary tract; neoplasms and immunosuppression; nutrition
and blood; musculoskeletal; eye; ear, nose, and orophar-
ynx; skin; immunological; and anesthetic. Centenarians
were considered to have been prescribed a drug from a
particular category if at least one relevant drug was pre-
scribed during their 100th year. Drugs relevant to more
than one category were counted in each. For example,
prednisolone is included in the endocrine and gastrointesti-
nal categories. Descriptive statistics were used to estimate
the total number of prescriptions before reaching the age
of 100, from the 95th year to the 100th year of life.
The frequency of PIP among centenarians was evaluated
using the updated 2012 American Geriatrics Society (AGS)
Beers Criteria.21 An expert group developed the criteria in
1991,22 with the latest revision by the AGS in 2012,21 to
provide explicit criteria for PIP in elderly adults. The criteria
include three primary groups: a list of potentially inappro-
priate medication (PIMs) to avoid independent of disease or
condition; a list of medications to be avoided in older per-
sons with specific diseases or conditions; and a list of PIMs
to be used with caution in older adults.21 This tool has been
widely used to evaluate PIP of drugs to elderly individuals in
a variety of settings.15–17,23–25
In the present study, we estimated the proportion of
centenarians receiving one or more prescriptions from each
overall Beers category, independent of disease or condition,
including—anticholinergics, anti-thrombotics, anti-infec-
tives, cardiovascular, CNS, endocrine, gastrointestinal, and
analgesics. The proportion prescribed at least one specific
PIM within each category was also estimated. The standard
criteria were used, rather than the disease-specific criteria,
because of the large population-based sample in the study.
The three drugs that were most frequently prescribed inap-
propriately were evaluated, and descriptive statistics were
used to determine the median number of PIMs in each cate-
gory. Desiccated thyroid is not listed in the BNF, so it was
excluded from the analysis. Glyburide is known as gliben-
clamide in the United Kingdom. The prescribing of nons-
teroidal anti-inflammatory drugs (NSAIDs) in this study was
considered inappropriate only if, as stated in the 2012 AGS
Beers Criteria, they were not taken with a gastroprotective
agent. All topical non-cyclooxygenase-selective NSAIDs
were not considered as inappropriate and only oral formula-
tions were included, as stated by the 2012 AGS Beers Cri-
teria. Stata version 13.0 was used to conduct all analysis
(Stata Corp., College Station, TX).
RESULTS
A cohort of 11,047 centenarians (8,982 women, 2,102
men), who reached the age of 100 between 1990 and 2013,
was selected for analysis. Eighty-four percent were born
between 1900 and 1913 and the remaining 16% between
1890 and 1899. The median annual number of prescriptions
was 7 (interquartile range 0–12) during the 100th year.
Table 1 shows the most frequently prescribed drugs at
the age of 100. Drug utilization for each drug class was
higher in women than in men, except for urinary tract
Table 1. Frequency of Different Categories of Pre-
scriptions According to Sex
Drug Class from
British National Formulary
Female,
n = 8,982
Male,
n = 2,102
All,
N = 11,084
n (%)a
Any 6,904 (79) 1,136 (54) 8,040 (73)
Cardiovascular 5,044 (56) 835 (40) 5,879 (53)
Central nervous
systemb
5,182 (58) 741 (35) 5,923 (53)
Gastrointestinal 4,488 (50) 752 (36) 5,240 (47)
Skin 3,524 (39) 537 (26) 4,061 (37)
Nutrition and blood 3,485 (39) 479 (23) 3,964 (36)
Antimicrobial 4,028 (45) 631 (30) 4,659 (42)
Eye 2,038 (23) 316 (15) 2,354 (21)
Musculoskeletal and
joint diseases
1,963 (22) 307 (15) 2,270 (20)
Endocrine 1,818 (20) 283 (13) 2,101 (19)
Respiratory 1,545 (17) 277 (13) 1,822 (16)
Anesthesia 1,131 (13) 198 (9) 1,329 (12)
Ear, nose, oropharynx 828 (9) 171 (8) 999 (9)
Immunological products
and vaccines
786 (9) 119 (6) 905 (8)
Gynecological and
urinary tract
692 (8) 206 (10) 898 (8)
Neoplasms and
immunosuppression
497 (6) 92 (4) 589 (5)
aFrequency of individuals with at least one prescription during the year
they turned 100.
bHypnotics, anxiolytics, antidepressants, analgesics, drugs for nausea and
vertigo, antiepileptics, drugs for parkinsonism and dementia.
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drugs. The most frequently prescribed drugs overall were
those affecting the CNS (53%), including hypnotics, anxi-
olytics, antidepressants, analgesics, drugs for nausea and
vertigo, antiepileptics, and antidementia, as well as cardio-
vascular (53%) and gastrointestinal (47%) drugs. The dis-
tribution of prescriptions issued to men and women
centenarians is shown in Figure 1. More than twice as
many men as women did not receive any prescriptions in
their 100th year, and the proportion of women was higher
than men for each increasing category of multiple prescrip-
tions.
The frequency of PIP according to the 2012 AGS
Beers Criteria is presented in Table 2. Overall, 32% of
centenarians were prescribed a PIM, and the three most
frequently prescribed PIMs were temazepam, amitriptyline,
and nitrofurantoin. The drug class with the highest pro-
portion of PIP was CNS medications (23%). Approxi-
mately one-fifth of centenarians (19% women, 13% men)
received anticholinergic drugs, with PIMs including chlor-
phenamine, hydroxyzine, and promethazine hydrochloride.
Despite the high levels of prescribing for gastrointestinal,
cardiovascular, and analgesic drugs, low levels of inappro-
priate prescribing (5%) were observed within these classes.
DISCUSSION
To the knowledge of the authors, this is the first popula-
tion-based study describing medication use and PIP in cen-
tenarians. Only a minority of centenarians did not receive
prescription medicines, with a higher proportion of men
not receiving any prescriptions, consistent with their super-
ior health status at age 100.18 Almost 80% of women and
54% of men were prescribed at least one drug during their
100th year. Sex differences in overall prescribing between
centenarians have not been reported previously. This dis-
parity could be because of sex differences in health-seeking
behavior, for example, not seeking a physician’s advice, or
nonadherence, as well as resulting from differences in
health status. Up to one-third of centenarians were pre-
scribed a PIM. The highest frequencies of PIP were attribu-
ted to the use of benzodiazepines (temazepam, diazepam),
amitriptyline, and nitrofurantoin. The 2012 AGS Beers
Criteria recommendation to avoid all of these drugs is
“strong,” and the reported quality of evidence is “high”
for avoiding temazepam, diazepam, and amitriptyline and
“moderate” for avoiding nitrofurantoin.21 The 2012 AGS
Beers Criteria recommend avoiding nitrofurantoin in indi-
viduals with creatinine clearance less than 60 mL/min
because of concerns about lack of efficacy from inadequate
drug concentrations in the urine. In view of the advanced
age of the cohort, it is likely that most will have poor
renal function and should therefore be using safer alterna-
tives such as ciprofloxacin or trimethoprim.26
Comparison with Existing Literature
Existing studies on drug utilization in elderly adults have
often focused on younger cohorts of old people7,9,10,12 or
do not include centenarians.9,13,14 There is scarce evidence
about PIP in extreme old age. These studies focusing on
younger elderly adults tend to rely on self-reported ques-
tionnaires and interviews,7,15–17,24,27 resulting in a high
risk of responder bias.
There have been no previous studies reporting PIP in a
large group of centenarians. Reports of prevalence of PIP
in individuals aged 65 and older are inconsistent, and few
studies have used the updated 2012 criteria. One study27
using the 2012 criteria reported a higher prevalence of PIP
(44%) in Spanish individuals aged 65 and older than the
present findings (32%) in centenarians. The most fre-
quently prescribed PIMs were benzodiazepines, similar to
the present data. Another study in New Zealand24 also
reported a higher PIM prevalence (42.7%) for community-
dwelling individuals aged 75 and older than for those aged
100 and older in CPRD, whereas another15 reported a
prevalence of 17%. All three studies15,24,27 used self-
reported data. Several studies reported pain medications as
the most commonly prescribed PIMs,15,17,23,24 including
two studies using the Screening Tool of Older People’s
potentially inappropriate Prescriptions/Screening Tool to
Alert doctors to the Right Treatment (STOPP/START) cri-
teria.28,29 This is inconsistent with the present findings in
centenarians, reporting CNS medications and anticholiner-
gics as the most commonly prescribed PIMs. It is not sta-
ted in all these previous studies whether concurrent use of
gastroprotective agents was considered alongside NSAIDs.
Strengths and Limitations
This study had the strengths of a large sample drawn from
a representative population of U.K. general practices. In
the United Kingdom, approximately 98% of individuals
are registered with a family practice, ensuring that the pre-
sent data are complete and nationally representative. Indi-
viduals aged 75 and older have an annual review of
medicines,30 and those with four or more medicines are
reviewed every 6 months, although this review was not
introduced until 2002. Using primary care EHRs allowed
for the classification of prescribing according to drug cate-
gory and of specific PIMs, but data were not available for
several variables of interest, including whether an individ-
ual lived alone or whether they lived in an urban or rural
location. EHRs circumvent the problem of recall bias, a
limitation of many drug use studies relying on self-reported
questionnaires or interviews to collect data on prescrip-
Figure 1. Frequency of prescriptions during 100th year
according to sex.
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tions. There is a possibility that some prescriptions will
not be filled or consumed, and the data may not capture
any over-the-counter or secondary care hospital prescrip-
tions, so the present findings may underestimate drug
usage of centenarians. Another limitation is that the sam-
ple was exposed to a nonuniform drug formulary because
the study considers data over a 23-year span. Medical
practice in primary care has evolved over time, and as a
result, certain drugs used in 1990 may now be considered
inappropriate. Several new drugs have also been intro-
duced that could not be prescribed in 1990.
There are limitations of the 2012 AGS Beers Criteria,
given their universal application without careful considera-
tion of an individual’s response to each drug.15,25 There
may also be some drugs used in the United Kingdom that
were not captured. In 2003, the STOPP/START criteria
were developed to identify potential errors in prescribing
and prescribing omission in older people according to
physiological system.24,28 These criteria were created as a
Europe-focused tool but are not as widely used as the
2012 AGS Beers Criteria to evaluate the epidemiology of
PIP because of their specificity. Although a more-indivi-
dualized tool may be favored in clinical practice, this
approach is less feasible for epidemiological investigation
of population-based samples. The 2012 AGS Beers Criteria
were specifically designed to use pharmacy records with
minimal additional clinical information so that they could
be applied to chart reviews or computerized data sets.21
According to the 2012 AGS Beers Criteria, the most
commonly prescribed PIMs in the present cohort were ben-
zodiazepines, tertiary tricyclic antidepressants, nitrofuran-
toin, and ibuprofen. The frequencies of PIP found in this
study should be interpreted cautiously because each per-
son’s risk:benefit ratio for a drug will depend on his or her
physiological and clinical status. Only an individual evalu-
ation of each person will confirm the validity of these
interpretations. Nevertheless, population-based studies pro-
vide useful epidemiological data on relative frequencies of
PIP in large cohorts and help identify the inappropriate
medications that are most frequently prescribed. This
study also identifies specific drugs that may be given more
attention in further research on the determinants of PIP in
elderly adults.
Conclusion and Implications for Clinical Practice
Polypharmacy and multimorbidity in elderly adults present
health professionals with a significant clinical responsibil-
ity. The limited empirically based evidence to guide drug
prescription in very old adults means that physicians must
base their prescribing decisions on clinical knowledge and
prior experience with similar conditions, likely from
younger cases. There is an urgent need for studies to
explore the efficacy, safety, and harms associated with
drug prescribing for different chronic conditions in very
old adults. There is also the need to model the adverse
clinical and economic consequences of inappropriate thera-
peutic decision-making in this group.
This is the first study to use primary care EHR data to
describe prescribing trends in UK centenarians, as well as
the extent of PIP according to drug class. It provides proof
of concept for using a large EHR database to evaluate
appropriateness of prescribing and a basis for reevaluating
indicators of appropriate prescribing as applied to this age
group. This also offers valuable data for the modeling of
future healthcare needs and costs of the oldest adults in
the United Kingdom.
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